Last reviewed · How we verify
Renuva Allograft Adipose Matrix
Renuva Allograft Adipose Matrix is a Tissue-engineered scaffold Biologic drug developed by University of Southern California. It is currently in Phase 3 development for Soft tissue reconstruction, including breast reconstruction and facial rejuvenation.
Renuva Allograft Adipose Matrix is a tissue-engineered scaffold derived from adipose tissue, used to promote tissue regeneration and repair.
Renuva Allograft Adipose Matrix is a tissue-engineered scaffold derived from adipose tissue, used to promote tissue regeneration and repair. Used for Soft tissue reconstruction, including breast reconstruction and facial rejuvenation.
At a glance
| Generic name | Renuva Allograft Adipose Matrix |
|---|---|
| Sponsor | University of Southern California |
| Drug class | Tissue-engineered scaffold |
| Modality | Biologic |
| Therapeutic area | Regenerative Medicine |
| Phase | Phase 3 |
Mechanism of action
It works by providing a supportive matrix for cells to grow and differentiate, facilitating the regeneration of damaged or missing tissue. This can be particularly useful for patients with limited donor sites or those who require more extensive tissue reconstruction.
Approved indications
- Soft tissue reconstruction, including breast reconstruction and facial rejuvenation
Common side effects
- Infection
- Seroma
- Wound complications
Key clinical trials
- Investigating the Clinical Impact of a Novel Adipose Allograft Matrix on Knee Fat Pad Impingement Treatment (PHASE1)
- Allograft Adipose Injectable for Vocal Fold Paralysis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Renuva Allograft Adipose Matrix CI brief — competitive landscape report
- Renuva Allograft Adipose Matrix updates RSS · CI watch RSS
- University of Southern California portfolio CI
Frequently asked questions about Renuva Allograft Adipose Matrix
What is Renuva Allograft Adipose Matrix?
How does Renuva Allograft Adipose Matrix work?
What is Renuva Allograft Adipose Matrix used for?
Who makes Renuva Allograft Adipose Matrix?
What drug class is Renuva Allograft Adipose Matrix in?
What development phase is Renuva Allograft Adipose Matrix in?
What are the side effects of Renuva Allograft Adipose Matrix?
Related
- Drug class: All Tissue-engineered scaffold drugs
- Manufacturer: University of Southern California — full pipeline
- Therapeutic area: All drugs in Regenerative Medicine
- Indication: Drugs for Soft tissue reconstruction, including breast reconstruction and facial rejuvenation
- Compare: Renuva Allograft Adipose Matrix vs similar drugs
- Pricing: Renuva Allograft Adipose Matrix cost, discount & access